These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15106308)

  • 21. Antimicrobial susceptibility testing of newer quinolones against gram positive and gram negative clinical isolates.
    Iffat W; Shoaib MH; Muhammad IN; Rehana ; Tasleem S; Gauhar S
    Pak J Pharm Sci; 2010 Jul; 23(3):245-9. PubMed ID: 20566434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coadministration of oral levofloxacin with agents that impair absorption: impact on antibiotic resistance.
    Cohen KA; Lautenbach E; Weiner MG; Synnestvedt M; Gasink LB
    Infect Control Hosp Epidemiol; 2008 Oct; 29(10):975-7. PubMed ID: 18808343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empiric, broad-spectrum antibiotic therapy with an aggressive de-escalation strategy does not induce gram-negative pathogen resistance in ventilator-associated pneumonia.
    Hibbard ML; Kopelman TR; O'Neill PJ; Maly TJ; Matthews MR; Cox JC; Vail SJ; Quan AN; Drachman DA
    Surg Infect (Larchmt); 2010 Oct; 11(5):427-32. PubMed ID: 20818984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
    Iakovlev VP; Svetukhin AM; Blatun LA; Ukhin SA
    Antibiot Khimioter; 2004; 49(8-9):57-65. PubMed ID: 15727148
    [No Abstract]   [Full Text] [Related]  

  • 26. Determination of the postantibiotic effect of ofloxacin on gram-negative bacteria utilizing a new method.
    Nilsson L; Isaksson B; Maller R; Nilsson M
    J Chemother; 1989 Jul; 1(4 Suppl):149-51. PubMed ID: 16312347
    [No Abstract]   [Full Text] [Related]  

  • 27. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
    Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial activity of alkaloidal fraction from barks of Himatanthus lancifolius.
    Souza WM; Stinghen AE; Santos CA
    Fitoterapia; 2004 Dec; 75(7-8):750-3. PubMed ID: 15567256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antibacterial activity of levofloxacin derivatives with certain bulky residues on piperazine ring.
    Foroumadi A; Emami S; Mansouri S; Javidnia A; Saeid-Adeli N; Shirazi FH; Shafiee A
    Eur J Med Chem; 2007 Jul; 42(7):985-92. PubMed ID: 17316916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Levofloxacin. expediency of high-dose regimens in therapy of lower respiratory tract infections].
    Guchev IA; Melekhina EV; Iudenich OV
    Antibiot Khimioter; 2011; 56(3-4):17-31. PubMed ID: 21913405
    [No Abstract]   [Full Text] [Related]  

  • 32. Composition and antimicrobial activity of the essential oil of Ballota pseudodictamnus L. Bentham.
    Couladis M; Chinou IB; Tzakou O; Loukis A
    Phytother Res; 2002 Dec; 16(8):723-6. PubMed ID: 12458473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
    J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.
    Hosgor-Limoncu M; Ermertcan S; Tasli H; Yurtman AN
    West Indian Med J; 2008 Mar; 57(2):106-11. PubMed ID: 19565951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of α-hydroxyalkylphosphonates as new antimicrobial agents.
    Faísca Phillips AM; Barros MT; Pacheco M; Dias R
    Bioorg Med Chem Lett; 2014 Jan; 24(1):49-53. PubMed ID: 24360606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial activity of some heterocyclic derivatives.
    Alsaleh FS; Gamal el-Din AY; Kandeel EM
    Microbios; 1995; 82(331):87-93. PubMed ID: 7609663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between 4-quinolone antibacterials and multivalent metal ions.
    Smith JT
    J Chemother; 1989 Jul; 1(4 Suppl):134-5. PubMed ID: 16312339
    [No Abstract]   [Full Text] [Related]  

  • 38. Levofloxacin and indolicidin for combination antimicrobial therapy.
    Ghaffar KA; Hussein WM; Khalil ZG; Capon RJ; Skwarczynski M; Toth I
    Curr Drug Deliv; 2015; 12(1):108-14. PubMed ID: 25213074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antibacterial activity of nitroaryl thiadiazole-levofloxacin hybrids.
    Foroumadi A; Mansouri S; Emami S; Mirzaei J; Sorkhi M; Saeid-Adeli N; Shafiee A
    Arch Pharm (Weinheim); 2006 Nov; 339(11):621-4. PubMed ID: 17036368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [sensitivity of bacteria to chemotherapeutic agents (Zurich, 1993)].
    Wüst J; Kayser FH
    Praxis (Bern 1994); 1995 Jan; 84(4):98-105. PubMed ID: 7846439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.